Tagrix 80mg (Osimertinib) What is Beacon?
Tagrix 80mg contains the main active ingredient Osimertinib mesylate, available in tablet form, which is indicated for use mainly in the targeted treatment of non-small cell lung cancer. The drug Tagrix 80mg (Osimertinib) Beacon has been tested and used in many countries, including Vietnam. Basic information Active ingredient: Osimertinib mesyl